Biotechnology & Medical Research

Intra-Cellular Therapies Inc prices $114 million public offering of common stock

Intra-Cellular Therapies Inc:Announced pricing of its previously announced underwritten public offering of 4,750,000 shares of its common stock at a public offering price of $24.00 per share.Net proceeds to Intra-Cellular Therapies from the sale of the shares, after deducting underwriting discounts...

9:00pm EST

GI Dynamics Inc's ENDO trial placed on enrollment hold

GI Dynamics Inc:Says that U.S. Food and Drug Administration (FDA) has placed a hold on enrollment in the company's ongoing pivotal clinical trial of EndoBarrier Therapy (the ENDO Trial) in the U.S. Monitoring and data collection involving patients currently enrolled in ENDO Trial will...

5:19pm EST

WuXi PharmaTech Cayman Inc gives Q1, FY 2015 guidance; EPS guidance below analysts' estimates;

WuXi PharmaTech Cayman Inc:Expects Q1 2015 total net revenues of $173-$175 million.Expects Q1 2015 GAAP diluted earnings per ADS of $0.20-$0.22.Expects Q1 2015 Non-GAAP diluted earnings per ADS of $0.30-$0.32.Expects FY 2015 total net revenues of $790-$800 million.Expects FY 2015 GAAP diluted...

4:30pm EST

Adocia SAS opens a subsidiary in the USA

Adocia SAS:Says creation of a subsidiary in the USA, Adocia Incorporated.Opening a US subsidiary is a key step in Adocia's strategy, the USA are currently the primary market for its products.

12:00pm EST

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

Analyst Research

Report Title Price
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00
Provider: Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.